1. Home
  2. MDGL vs TX Comparison

MDGL vs TX Comparison

Compare MDGL & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • TX
  • Stock Information
  • Founded
  • MDGL 2011
  • TX 1961
  • Country
  • MDGL United States
  • TX Luxembourg
  • Employees
  • MDGL N/A
  • TX N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • TX Steel/Iron Ore
  • Sector
  • MDGL Health Care
  • TX Industrials
  • Exchange
  • MDGL Nasdaq
  • TX Nasdaq
  • Market Cap
  • MDGL 6.8B
  • TX 5.9B
  • IPO Year
  • MDGL N/A
  • TX 2006
  • Fundamental
  • Price
  • MDGL $319.93
  • TX $29.13
  • Analyst Decision
  • MDGL Buy
  • TX Buy
  • Analyst Count
  • MDGL 9
  • TX 3
  • Target Price
  • MDGL $386.29
  • TX $41.00
  • AVG Volume (30 Days)
  • MDGL 333.2K
  • TX 217.6K
  • Earning Date
  • MDGL 05-01-2025
  • TX 04-29-2025
  • Dividend Yield
  • MDGL N/A
  • TX 9.27%
  • EPS Growth
  • MDGL N/A
  • TX N/A
  • EPS
  • MDGL N/A
  • TX N/A
  • Revenue
  • MDGL $180,133,000.00
  • TX $17,649,060,000.00
  • Revenue This Year
  • MDGL $230.69
  • TX N/A
  • Revenue Next Year
  • MDGL $74.76
  • TX $7.00
  • P/E Ratio
  • MDGL N/A
  • TX N/A
  • Revenue Growth
  • MDGL N/A
  • TX 0.22
  • 52 Week Low
  • MDGL $189.00
  • TX $24.00
  • 52 Week High
  • MDGL $377.46
  • TX $44.25
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 50.76
  • TX 52.77
  • Support Level
  • MDGL $276.20
  • TX $26.75
  • Resistance Level
  • MDGL $330.64
  • TX $27.59
  • Average True Range (ATR)
  • MDGL 20.79
  • TX 1.36
  • MACD
  • MDGL 0.06
  • TX 0.24
  • Stochastic Oscillator
  • MDGL 76.56
  • TX 92.93

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel, Usiminas and Mining. In its steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The Usiminas segment include iron ore extraction, steel transformation, production of capital goods and logistics. The vast majority of its revenue comes from the steel segment and geographically from Mexico.

Share on Social Networks: